GRACEcast
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 1): Potential Value of Molecular Staging (audio)
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:12:38
- More information
Informações:
Synopsis
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, explains the potential utility of molecularly guided staging of patients with early stage non-small cell lung cancer (NSCLC).
